RVC October 2024 Investor Forum

RVC October 2024 Investor Forum

Hosted Virtually via Zoom

Please join us virtually for pitches from a few great companies, investor updates on deals-in-play, and to discuss what we’re seeing in the world of angel investing. The October Investor Forum will be the last investor forum in 2024, and we're hoping to see as many of you as possible online to make this a great event!

RVC Investor Forums bring together accredited angel investors interested in fast-growing, early-stage companies in Colorado. These forums serve to pool the wisdom, expertise, and capital of many individual angels. At this forum, investor members will hear pitches, and afterwards the founders are excused and investors discuss the merits and risks of each venture. There is no requirement to invest and each investor has an opportunity to indicate interest in following or leading a specific deal. Both new and experienced investor members are welcome at forums -- this is the best way to learn hands-on about angel investing! 

Meeting Agenda:

Welcome and Introductions

3:00pm to 3:15 pm

3:15 pm to 4:00pm

Investor Only Discussion

4:00 to 4:30pm

Deal-in-Play Discussion

4:30pm to 5:00pm

Presenting Companies

Pomarium introduces a groundbreaking technology that enables financial advisors to collaboratively create portfolios with their clients on demand. This innovation integrates advisors' investment goals with clients' personal values, offering tailored portfolios for all clients, irrespective of account size, without compromising on investment quality.

Electric Outdoors is on a mission to revolutionize how people access the outdoors sustainably. Its flagship product, the EO Canopy, is a sw-enabled, portable, solar-powered, off-grid camping platform that enables landowners to unlock new land and destinations and generate new revenue streams without the burden and cost of infrastructure development.

TYBR Health has developed B3 GEL, the first versatile, flowable biologic barrier gel designed to protect healing tissues and prevent scarring and adhesions—common post-surgical complications that prolong recovery and drive up healthcare costs. Engineered for both open and minimally invasive procedures, B3 GEL initially focuses on tendon and ligament repairs, which are often associated with chronic stiffness and pain. TYBR Health is backed by Y Combinator and Medtech Innovator.

[1 more company to be confirmed]

To attend this event, you must be accredited: Net worth of at least one million US dollars, not including the value of one’s primary residence, or have made at least $200,000 each year for the last two years [or $300,000 if jointly filing] and have the expectation to make the same amount this year. We do not require a minimum investment.